Resistance to teicoplanin developing during treatment of methicillin-resistant Staphylococcus aureus infection.
Elsaghier
Ashraf A F
AA
Royal Free and University College Medical School, University College London, Royal Free Campus, Department of Medical Microbiology, London NW3 2PF, UK.
Aucken
Hazel M
HM
Hamilton-Miller
Jeremy M
JM
Shaw
Stephen
S
Kibbler
Christopher C
CC
D000293:Adolescent; D000368:Aged; D000900:Anti-Bacterial Agents / Q000494:pharmacology / Q000627:therapeutic use; D024881:Drug Resistance, Bacterial / Q000502:physiology; D006801:Humans; D008297:Male; D016106:Methicillin Resistance / Q000502:physiology*; D008826:Microbial Sensitivity Tests / Q000706:statistics & numerical data; D013203:Staphylococcal Infections / Q000188:drug therapy* / Q000382:microbiology*; D013211:Staphylococcus aureus / Q000187:drug effects* / Q000254:growth & development; D017334:Teicoplanin / Q000494:pharmacology* / Q000627:therapeutic use*
D000900:Anti-Bacterial Agents; D017334:Teicoplanin